Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis

ConclusionThese data suggest that an aggressive therapy should be established after NTZ with the shortest possible wash ‐out period. AHSCT after six months from NTZ withdrawal seems safe.This article is protected by copyright. All rights reserved.

Source: European Journal of Neurology - November 10, 2018 Category: Neurology Authors: Alice Mariottini, Chiara Innocenti, Benedetta Forci, Eliana Magnani, Claudia Mechi, Alessandro Barilaro, Riccardo Nistri, Arianna Fani, Riccardo Saccardi, Luca Massacesi, Anna Maria Repice Tags: Original Article Source Type: research